Table 1 Baseline characteristics of patients in the training and testing cohorts
Patients characteristics | Training cohort | Testing cohort |
|---|---|---|
n = 2336 | n = 2371 | |
Male, n (%) | 1530 (65.5) | 1589 (67.0) |
Age, median [IQR] | 63 [52–75] | 64 [53–74] |
< 40 years, n (%) | 203 (8.7) | 218 (9.2) |
40–59 years, n (%) | 774 (33.1) | 700 (29.5) |
60–69 years, n (%) | 538 (23.0) | 586 (24.7) |
70–74 years, n (%) | 253 (10.8) | 277 (11.7) |
75–80 years, n (%) | 248 (10.6) | 284 (12.0) |
≥ 80 years, n (%) | 320 (13.7) | 306 (12.9) |
Diabetes, n (%) | 460 (19.7) | 146 (6.2) |
BMI2, median [IQR] | 25.7 [22.5–29.3] | 26.9 [23.1–30.2] |
Obesity3, n (%) | 498 (21.3) | 622 (26.3) |
Immunosuppression, n (%) | 244 (10.5) | 238 (10.0) |
Body temperature ≥ 39 °C | 125 (5.4) | |
SAPS21, median [IQR] | 57 [45–72] | 57 [43–72] |
Vasopressors use, n (%) | 1455 (69.8) | 1292 (54.5) |
Creatinine > 100 µM, n (%) | 1093 (46.8) | 1131 (47.7) |